Benign neoplasm: Brain, supratentorial

CD2_BENIGN_BRAIN_SUPRATENT

salivary gland neoplasm: ['Tumors of the SALIVARY GLANDS.']

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D33.0
Cause of death: ICD-10 D33.0

2 out of 7 registries used, show all original rules.

431

diagram downward connector

Check minimum number of events None

431

diagram downward connector

Include endpoints None

431

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

419

diagram downward connector
CD2_BENIGN_BRAIN_SUPRATENT

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D33
Name in latin Neoplasma benignum cerebri supratentoriale

Similar endpoints

List of similar endpoints to Benign neoplasm: Brain, supratentorial based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 419 226 193
Unadjusted prevalence (%) 0.11 0.11 0.12
Mean age at first event (years) 48.83 46.82 51.17

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CD2_BENIGN_BRAIN_SUPRATENT – Benign neoplasm: Brain, supratentorial
GWS hits:

Survival analyses between endpoints

Plot

before Benign neoplasm: Brain, supratentorial
after Benign neoplasm: Brain, supratentorial

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Benign neoplasm: Brain, supratentorial

Endpoint not on priority list, no data to show.